Extended imatinib improves survival in GIST | Gastroenterology Update
Links shared publicly online about this topic.
- 235total visits
Extended imatinib improves survival in GIST | Gastroenterology Update
gastroenterologyupdate.com.au —
Extended adjuvant therapy with imatinib dramatically increases survival in patients with operable gastrointestinal stromal tumour, research presented at the American Society of Clinical Oncology annual congress shows.
View full resource at gastroenterologyupdate.com.au
Tags: Gastroenterology, Leukemia Medication, Gleevec, Glivec, Oncology
Most Recently Shared on June 8, 2011 at 4:00 am By:
Extended imatinib improves survival in GIST http://bit.ly/iBz2L0 #gastroenterology
Advertisement
